Aptys Pharmaceuticals

APTYS Tablets APTYS emulsion APTYS BiGel APTYS tablet APTYS fluidbed
APTYS analysts APTYS effervescent APTYS mixer

Whether you are developing a new chemical / biochemical entity, a generic or a reformulated marketed or an off-patent drug, the time to market is driven by several steps from lead optimisation to pre-market industrialisation, from early preclinical experiments to advanced clinical phases. Key issues in the development of your drug product are the design of the product, its pharmaceutical development and its manufacturing.

APTYS has helped several companies advance their drug candidate through these steps by proposing innovative drug delivery concepts and proprietary technologies, and by taking over formulation development, analytical development and technology transfer to qualified manufacturers.

APTYS CAN HELP YOU DEVELOP A DRUG PRODUCT OF YOUR DRUG CANDIDATE.

PDF - 304.6 kb
Download brochure
PDF - 267.6 kb
Certification ISO9001

News

  • June 18-21, 2012 : BIO International convention, Boston (USA) (Booth 1043)
  • 25-27 October 2011 : ICSE, Frankfurt (Germany) (Booth 41J45)
  • 10-12 October 2011 : Biopartnering, London (England)

All the news

Contact Us

Aptys Pharmaceuticals
Biopôle Clermont-Limagne
F-63360 Saint Beauzire, France
See the map

contact@aptys-pharmaceuticals.com